Solicure 5 mg Tablets

Solicure – Solifenacin Succinate 5 mg Tablets

Solicure is a pharmaceutical formulation containing Solifenacin Succinate 5 mg. Solifenacin belongs to the antimuscarinic class of medicines and is used for the management of overactive bladder symptoms in adults.

What Is Solicure Used For?

Solicure is used for the treatment of overactive bladder with symptoms such as urinary urgency, urinary frequency and urge urinary incontinence.

Overactive bladder can cause a sudden and difficult-to-control urge to urinate, frequent urination and involuntary leakage of urine. Solifenacin helps relax the bladder muscle and can reduce these symptoms when prescribed appropriately.

Uses of Solicure

Solicure may be used for:

• Overactive bladder
• Urinary urgency
• Increased urinary frequency
• Urge urinary incontinence
• Sudden urges to urinate
• Frequent urination associated with overactive bladder
• Urinary leakage associated with urge incontinence
• Symptoms caused by involuntary bladder contractions

How Does Solicure Work?

Solifenacin is a muscarinic receptor antagonist. It works by reducing the activity of muscarinic receptors in the bladder.

In overactive bladder, involuntary contractions of the bladder muscle can create a sudden urge to urinate, increased urinary frequency and urinary leakage.

By reducing these unwanted bladder contractions, Solifenacin can help increase bladder control and reduce the frequency and urgency of urination. :contentReference[oaicite:2]{index=2}

Overactive Bladder

Overactive bladder is a condition characterized by urinary urgency, often accompanied by increased urinary frequency and, in some patients, urge urinary incontinence.

These symptoms can interfere with daily activities and may affect quality of life.

Solicure provides pharmacological management of these symptoms by helping relax the bladder muscle and reduce involuntary bladder activity.

Urinary Urgency

Urinary urgency refers to a sudden and difficult-to-control need to urinate. It is one of the characteristic symptoms of overactive bladder.

Solifenacin can help reduce bladder overactivity and thereby support better control over sudden urinary urges.

Urinary Frequency

People with overactive bladder may need to urinate more frequently than usual. Solifenacin may help reduce urinary frequency by decreasing involuntary bladder contractions.

Urge Urinary Incontinence

Urge urinary incontinence occurs when a sudden, strong urge to urinate is followed by involuntary leakage of urine.

Solifenacin is indicated for adults with overactive bladder accompanied by urge urinary incontinence, urgency and urinary frequency. :contentReference[oaicite:3]{index=3}

Product Information

Brand Name: Solicure

Composition: Solifenacin Succinate

Strength: 5 mg

Dosage Form: Tablets

Route of Administration: Oral

Therapeutic Segment: Urology

Primary Indication: Overactive Bladder

Packing: 10 x 10 Tablets

Key Product Highlights

• Solifenacin Succinate 5 mg formulation
• Antimuscarinic therapy
• Used for overactive bladder symptoms
• Helps manage urinary urgency
• Helps manage urinary frequency
• Used for urge urinary incontinence
• Oral tablet dosage form
• Relevant to urological care

Role in Urological Care

Overactive bladder can involve involuntary bladder contractions that result in urgency, increased urinary frequency and urinary leakage.

Antimuscarinic therapy is one of the pharmacological approaches used for managing these symptoms. Solifenacin works on muscarinic receptors involved in bladder contraction and helps reduce unwanted bladder activity.

Solicure is therefore relevant to pharmaceutical portfolios focused on overactive bladder management and urological care.

Important Information

Solicure is a prescription medicine and should be used under the guidance of a qualified healthcare professional.

The recommended starting dose of Solifenacin Succinate is generally 5 mg once daily, and the dose may be increased to 10 mg once daily when appropriate and well tolerated, according to the prescribing information. :contentReference[oaicite:4]{index=4}

The tablet should be swallowed with water and should not be split, chewed or crushed unless specifically directed by a healthcare professional. It may be taken with or without food. :contentReference[oaicite:5]{index=5}

Solifenacin may cause side effects such as dry mouth, constipation, blurred vision or dizziness. Patients should discuss persistent or significant side effects with their healthcare professional.

Solifenacin should not be used in patients with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma or known hypersensitivity to the medicine or its ingredients. :contentReference[oaicite:6]{index=6}

Patients with kidney or liver problems should inform their healthcare professional before treatment because dosage limitations may apply in certain conditions. :contentReference[oaicite:7]{index=7}

Storage

Store the product according to the storage conditions stated on the approved product label.

Keep the tablets in their original packaging and keep them out of reach of children.

Product Summary

Solicure contains Solifenacin Succinate 5 mg and is used for the management of overactive bladder symptoms in adults.

It is primarily relevant to urinary urgency, urinary frequency and urge urinary incontinence associated with overactive bladder.

Its therapeutic positioning makes Solicure suitable for urology-focused pharmaceutical portfolios and products addressing bladder control and overactive bladder management.